Effect of severe acute respiratory syndrome coronavirus 2 infection during pregnancy in K18-hACE2 transgenic mice

Effect of severe acute respiratory syndrome coronavirus 2 infection during pregnancy in K18-hACE2 transgenic mice

Objective This study aimed to examine the influence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection on pregnancy in cytokeratin-18 (K18)-hACE2 transgenic mice. Methods To determine the expression of hACE2 mRNA in the female reproductive tract of K18-hACE2 mice, real-time po...

Full description

Bibliographic Details
Main Authors:	Byeongseok Kim, Ki Hoon Park, Ok-Hee Lee, Giwan Lee, Hyukjung Kim, Siyoung Lee, Semi Hwang, Young Bong Kim, Youngsok Choi
Format:	Article
Language:	English
Published:	Asian-Australasian Association of Animal Production Societies 2023-01-01
Series:	Animal Bioscience
Subjects:	implantation k18-hace2 transgenic mouse pregnancy sars-cov-2
Online Access:	http://www.animbiosci.org/upload/pdf/ab-22-0143.pdf

Similar Items

K18- and CAG-hACE2 Transgenic Mouse Models and SARS-CoV-2: Implications for Neurodegeneration Research
by: Simona Dedoni, et al.
Published: (2022-06-01)

Comparison of the pathogenesis of SARS-CoV-2 infection in K18-hACE2 mouse and Syrian golden hamster models
by: Haengdueng Jeong, et al.
Published: (2022-11-01)

The lethal K18-hACE2 knock-in mouse model mimicking the severe pneumonia of COVID-19 is practicable for antiviral development
by: Zhen Zhang, et al.
Published: (2024-12-01)

Elimination of olfactory sensory neurons by zinc sulfate inoculation prevents SARS-CoV-2 infection of the brain in K18-hACE2 transgenic mice
by: Ji-Hun Lee, et al.
Published: (2024-11-01)

Immunogenicity and Protectivity of Sputnik V Vaccine in hACE2-Transgenic Mice against Homologous and Heterologous SARS-CoV-2 Lineages Including Far-Distanced Omicron BA.5
by: Inna V. Dolzhikova, et al.
Published: (2024-10-01)

Neuropathological lesions in intravenous BCG-stimulated K18-hACE2 mice challenged with SARS-CoV-2
by: Lidia Sánchez-Morales, et al.
Published: (2024-05-01)

Post‐COVID pulmonary injury in K18‐hACE2 mice shows persistent neutrophils and neutrophil extracellular trap formation
by: Stefanos Giannakopoulos, et al.
Published: (2024-08-01)

A longitudinal molecular and cellular lung atlas of lethal SARS-CoV-2 infection in K18-hACE2 transgenic miceResearch in context
by: Seunghoon Choi, et al.
Published: (2024-01-01)

Intranasal Liposomal Formulation of Spike Protein Adjuvanted with CpG Protects and Boosts Heterologous Immunity of hACE2 Transgenic Mice to SARS-CoV-2 Infection
by: Momtchilo Russo, et al.
Published: (2023-11-01)

Mouse models of lung-specific SARS-CoV-2 infection with moderate pathological traits
by: Sung-Hee Kim, et al.
Published: (2022-11-01)

Corrigendum: Mouse models of lung-specific SARS-CoV-2 infection with moderate pathological traits
by: Sung-Hee Kim, et al.
Published: (2022-12-01)

Proteomic and phosphoproteomic characteristics of the cortex, hippocampus, thalamus, lung, and kidney in COVID-19-infected female K18-hACE2 miceResearch in context
by: Jiang-Feng Liu, et al.
Published: (2023-04-01)

H1N1 exposure during the convalescent stage of SARS-CoV-2 infection results in enhanced lung pathologic damage in hACE2 transgenic mice
by: Heng Li, et al.
Published: (2021-01-01)

Virulence Profiles of Wild-Type, P.1 and Delta SARS-CoV-2 Variants in K18-hACE2 Transgenic Mice
by: Yasmin da Silva Santos, et al.
Published: (2023-04-01)

Prolonged Protective Immunity Induced by Mild SARS-CoV-2 Infection of K18-hACE2 Mice
by: Liat Bar-On, et al.
Published: (2022-04-01)

Neuroinvasion and Encephalitis Following Intranasal Inoculation of SARS-CoV-2 in K18-hACE2 Mice
by: Pratima Kumari, et al.
Published: (2021-01-01)

Functional heterogeneity of mesenchymal stem cells and their therapeutic potential in the K18-hACE2 mouse model of SARS-CoV-2 infection
by: Kátia Nunes da Silva, et al.
Published: (2025-01-01)

Protection of K18-hACE2 Mice against SARS-CoV-2 Challenge by a Capsid Virus-like Particle-Based Vaccine
by: Sebenzile K. Myeni, et al.
Published: (2024-07-01)

Single MVA-SARS-2-ST/N Vaccination Rapidly Protects K18-hACE2 Mice against a Lethal SARS-CoV-2 Challenge Infection
by: Sabrina Clever, et al.
Published: (2024-03-01)

Effective protection of ZF2001 against the SARS-CoV-2 Delta variant in lethal K18-hACE2 mice
by: Lianlian Bian, et al.
Published: (2022-05-01)

Modeling SARS-CoV-2 Infection in Mice Using Lentiviral hACE2 Vectors Infers Two Modes of Immune Responses to SARS-CoV-2 Infection
by: Chaja Katzman, et al.
Published: (2021-12-01)

Mouse-Adapted SARS-CoV-2 MA10 Strain Displays Differential Pulmonary Tropism and Accelerated Viral Replication, Neurodissemination, and Pulmonary Host Responses in K18-hACE2 Mice
by: Côme J. Thieulent, et al.
Published: (2023-02-01)

Enhancing human ACE2 expression in mouse models to improve COVID‐19 research
by: Sun Jiaoyang, et al.
Published: (2025-02-01)

SARS-CoV-2 omicron BA.5 and XBB variants have increased neurotropic potential over BA.1 in K18-hACE2 mice and human brain organoids
by: Romal Stewart, et al.
Published: (2023-11-01)

Immunodominant Linear B-Cell Epitopes of SARS-CoV-2 Spike, Identified by Sera from K18-hACE2 Mice Infected with the WT or Variant Viruses
by: Yinon Levy, et al.
Published: (2022-02-01)

VSV-ΔG-Spike Candidate Vaccine Induces Protective Immunity and Protects K18-hACE2 Mice against SARS-CoV-2 Variants
by: Yfat Yahalom-Ronen, et al.
Published: (2023-06-01)

Early pathogenesis profiles across SARS-CoV-2 variants in K18-hACE2 mice revealed differential triggers of lung damages
by: Zhen Qin Aw, et al.
Published: (2022-10-01)

Newly Proposed Dose of Daclatasvir to Prevent Lethal SARS-CoV-2 Infection in Human Transgenic ACE-2 Mice
by: Mayara Mattos, et al.
Published: (2024-11-01)

Matrix Metalloproteinases Expression Is Associated with SARS-CoV-2-Induced Lung Pathology and Extracellular-Matrix Remodeling in K18-hACE2 Mice
by: Hila Gutman, et al.
Published: (2022-07-01)

Chimeric Virus-like Particle-Based COVID-19 Vaccine Confers Strong Protection against SARS-CoV-2 Viremia in K18-hACE2 Mice
by: Challika Kaewborisuth, et al.
Published: (2022-05-01)

Analysis of spike protein variants evolved in a novel in vivo long-term replication model for SARS-CoV-2
by: Dongbum Kim, et al.
Published: (2023-11-01)

Computational design of medicinal compounds to inhibit RBD-hACE2 interaction in the Omicron variant: unveiling a vulnerable target site
by: Muhammad Shahab, et al.
Published: (2023-01-01)

Comparison of transgenic and adenovirus hACE2 mouse models for SARS-CoV-2 infection
by: Raveen Rathnasinghe, et al.
Published: (2020-01-01)

The influence of SARS‐CoV‐2 infection on expression of drug‐metabolizing enzymes and transporters in a hACE2 murine model
by: Kiran Deshpande, et al.
Published: (2023-06-01)

The protection of CoronaVac against the infection of wild‐type SARS‐CoV‐2 (WH‐09) or Omicron variant in nude‐hACE2 mice
by: Kaili Lin, et al.
Published: (2023-08-01)

A siRNA targets and inhibits a broad range of SARS‐CoV‐2 infections including Delta variant
by: Yi‐Chung Chang, et al.
Published: (2022-02-01)

Differences in Susceptibility to SARS-CoV-2 Infection Among Transgenic hACE2-Hamster Founder Lines
by: Scott A. Gibson, et al.
Published: (2024-10-01)

A highly susceptible hACE2-transgenic mouse model for SARS-CoV-2 research
by: Gang Liu, et al.
Published: (2024-02-01)

The pH Effects on SARS-CoV and SARS-CoV-2 Spike Proteins in the Process of Binding to hACE2
by: Yixin Xie, et al.
Published: (2022-02-01)

A humanised ACE2, TMPRSS2, and FCGRT mouse model reveals the protective efficacy of anti-receptor binding domain antibodies elicited by SARS-CoV-2 hybrid immunityResearch in context
by: Fernanda Ana-Sosa-Batiz, et al.
Published: (2025-03-01)